Three-phase treatment offers patients with HSV infections an alternative to perpetual antiviral management ROATAN, BAY ...

The new oral therapy demonstrates superior lesion healing for complex patients who have few current treatment options.

A phase 3 trial finds pritelivir significantly improves cure rates for immunocompromised individuals with refractory HSV infections.

Pritelivir met its primary endpoint of superior lesion healing, achieving a 62.7% lesion healing rate compared to 34.0% with standard-of-care ...

Please provide your email address to receive an email when new articles are posted on . Despite a decline in herpes simplex virus type 2 infections over the course of decades, researchers calculated ...

Herpes simplex virus 2 (HSV-2) is a sexually transmitted infection that can cause painful, recurrent lesions in the genital skin and mucosa. HSV-2 initially infects genital epithelial cells before ...

Vaccines are one of the most important medical inventions of modern times that have saved and enhanced innumerable lives around the world. Despite the technological advances in vaccine design and ...

The researchers found 25.6 million people aged 15 to 49 years had new HSV-2 infections and 519.5 million (13.3%) had existing (prevalent) HSV-2 infections globally in 2020. (HealthDay News) — The ...

Serum YKL-40 levels in patients with cervical cancer are elevated compared to patients with cervical intraepithelial neoplasia and healthy controls No significant financial relationships to disclose.

Objective: The objective of this study was to provide information on the prevalence of herpes simplex infections in the general population in Europe. Goals: The goals of this study were to determine ...